This industry profile provides a five-year forecast for Canada’s Pharmaceutical Products Industry.
Canada’s Pharmaceutical Products Industry: Industrial Profile Winter 2013
Canada’s Pharmaceutical Products Industry: Industrial Profile Winter 2013
Industry Economic Analysis
$595.00
- Patented Drug Prices—Patented drug prices have not kept up with increases in the consumer price index, limiting revenue growth.
- R&D Spending—R&D spending fell by 6.6 per cent from 2001 to 2011, which may result in fewer new drugs being developed.
- Expenditures on Drugs—Pharmaceuticals have become the second-largest component of health care expenditures in Canada.
Customers Who Downloaded This Also Liked
Require an accessible version of this research?
Upon request, Signal49 Research offers accessible versions of research. Please contact us to request your accessible version.
Learn more about our accessibility policies.
Effective January 26, 2026, AERIC Inc./Signal49 Research discontinued use of ‘The Conference Board of Canada’ name, logo and branding, which had been used by AERIC Inc./Signal49 Research under license from The Conference Board, Inc. The Conference Board, Inc. and its licensees, which are not affiliated with Signal49 Research, own all right, title and interest in THE CONFERENCE BOARD name and trademarks in Canada and have the exclusive right to their use in Canada since January 26, 2026.
